HomeCompareZGXNF vs JNJ

ZGXNF vs JNJ: Dividend Comparison 2026

ZGXNF yields 2.43% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ZGXNF wins by $153.01M in total portfolio value
10 years
ZGXNF
ZGXNF
● Live price
2.43%
Share price
$3.06
Annual div
$0.07
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$153.04M
Annual income
$141,837,707.22
Full ZGXNF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — ZGXNF vs JNJ

📍 ZGXNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZGXNFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZGXNF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ZGXNF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZGXNF
Annual income on $10K today (after 15% tax)
$206.67/yr
After 10yr DRIP, annual income (after tax)
$120,562,051.14/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, ZGXNF beats the other by $120,558,065.15/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZGXNF + JNJ for your $10,000?

ZGXNF: 50%JNJ: 50%
100% JNJ50/50100% ZGXNF
Portfolio after 10yr
$76.54M
Annual income
$70,921,198.31/yr
Blended yield
92.66%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ZGXNF
No analyst data
Altman Z
3.7
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZGXNF buys
0
JNJ buys
0
No recent congressional trades found for ZGXNF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZGXNFJNJ
Forward yield2.43%2.13%
Annual dividend / share$0.07$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$153.04M$30.3K
Annual income after 10y$141,837,707.22$4,689.40
Total dividends collected$152.18M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ZGXNF vs JNJ ($10,000, DRIP)

YearZGXNF PortfolioZGXNF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,186$486.27$10,592$272.30+$594.00ZGXNF
2$12,986$1,016.75$11,289$357.73+$1.7KZGXNF
3$16,101$2,206.23$12,123$472.89+$4.0KZGXNF
4$22,341$5,113.07$13,141$629.86+$9.2KZGXNF
5$37,166$13,261.06$14,408$846.81+$22.8KZGXNF
6$81,003$41,234.77$16,021$1,151.60+$65.0KZGXNF
7$254,654$167,980.64$18,122$1,588.22+$236.5KZGXNF
8$1,259,566$987,086.10$20,930$2,228.20+$1.24MZGXNF
9$10,473,558$9,125,822.70$24,792$3,191.91+$10.45MZGXNF
10$153,044,414$141,837,707.22$30,274$4,689.40+$153.01MZGXNF

ZGXNF vs JNJ: Complete Analysis 2026

ZGXNFStock

ZIGExN Co., Ltd. operates the life media platform in Japan. It operates Job change EX, a job change and job information site; Dispatch EX, a Website covering job information and dispatch company information of staffing sites and dispatching companies; Part-timer EX, a part time job search service site; d job, a job recruitment information and smartphone work recruitment service; Nurse Job EX, a nurse recruitment/career change site; and Pharmacist Job EX, a pharmacist recruitment information search site. The company also offers Rental Smocca, a search site for real estate rental housing listings; Maisumi EX, a site specialized in real estate sale, land utilization, and rental management; and Moving estimate EX, a site that offers moving estimates. In addition, it provides SmaRE, a marketing support tool for the purchase and sale of real estate properties; Minorino, a used condominium sales portal site specializing in renovation; and Provider EX, a comparison site that helps in selecting high-speed mobile communication. Further, the company offers used car EX, an used car information site; Car purchase EX, a comparison site for car purchase; Car-tana, a used car export portal site; Apple world, a portal for hotel booking; Hotelista, a hotel reservation Website; Travery, a comparison site for hotel reservations; and tradecarview, a used car export site. In addition it offers Puronuri, a service that allows to collect information and compare estimates for exterior wall painting; Exterior wall painting concierge is a free matching service; Enepi a price comparison service; Guriene, a service that supports the smart and profitable introduction of solar power generation; Hotelista, a hotel reservation site; Traveler, a comparison / reservation site for low-cost flights and LCCs; Nursery rhyme, a baby sitter service; and franchise, marriage, tutor, and study abroad comparison sites. ZIGExN Co., Ltd. was founded in 2006 and is headquartered in Tokyo, Japan.

Full ZGXNF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this ZGXNF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZGXNF vs SCHDZGXNF vs JEPIZGXNF vs OZGXNF vs KOZGXNF vs MAINZGXNF vs ABBVZGXNF vs MRKZGXNF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.